Past And Present View on NBIX
The biotech space remains red hot with the XBI almost completing its "V Shaped" recovery. It trades just 2% below a double bottom pivot of 98.86, and will have a formidable challenge at the very round par number which has been significant resistance. If it can break above that area soundly the group will get a big boost obviously. Below is the chart of NBIX and how it appeared in our 4/21 Healthcare Note. Biotech play lower by 6% YTD and higher by 29% over last one year period. Nice start to this week after prior two jumped by a combined 15%. Prone to strong moves with 25 of 32 week winning streak between weeks ending 5/3-12/6/19 (4 of 7 WEEKLY decliners fell less than 1%). Four of last five earnings reactions lower by .6, .1, 5.9 and 3.8% on 2/5, 11/5, 4/30 and 2/6/19. Enter on pullback into very round number/break above long downtrend line. Entry NBIX 100.40. Stop 95.